Understanding Atopic Dermatitis: Advances in Treatment and Management By Dr. Lauren Penzi, MD, FAAD

Atopic dermatitis (AD), often referred to as eczema, is a chronic skin condition that causes inflammation, itching, and dryness. Affecting millions of people globally, AD can have a profound impact on quality of life, particularly for those with severe cases. As a dermatologist at MDCS Dermatology, I’ve seen firsthand how frustrating and persistent this condition can be. However, recent advances in treatment provide new hope for patients seeking relief.

What is Atopic Dermatitis?
Atopic dermatitis is a type of eczema that typically begins in childhood but can persist or even start in adulthood. It is characterized by red, inflamed, and itchy patches of skin, most commonly affecting the face, elbows, and knees. The exact cause is still not fully understood, but it is believed to be linked to a combination of genetic and environmental factors. Individuals with AD often have an overactive immune response to allergens or irritants, leading to inflammation of the skin.

Advances in Treatment: A New Era for Patients
The good news for those suffering from atopic dermatitis is the recent surge in new treatments that target the underlying causes of the disease rather than just managing symptoms. Here are some of the most significant developments:

1. Biologic Therapies
   One of the most exciting advances in the treatment of AD is the introduction of biologic therapies. These are targeted treatments designed to block specific immune responses involved in the inflammation seen in AD. The most well-known biologic for AD is dupilumab (Dupixent), which has been a game-changer for many patients. It works by blocking the interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways, which are critical in the inflammatory process of atopic dermatitis. Patients using dupilumab often report significant reductions in itching and skin inflammation, allowing them to experience long-term relief.
2. Janus Kinase (JAK) Inhibitors
   JAK inhibitors are another promising treatment option for moderate to severe atopic dermatitis. These oral medications work by interfering with signaling pathways that contribute to the inflammatory response. Upadacitinib (Rinvoq)  and abrocitinib (Cibinqo) are two JAK inhibitors recently approved for treating AD. These drugs offer rapid improvement in symptoms, often within weeks of starting treatment, and provide an alternative for patients who do not respond to biologics.
3. Topical Therapies
   For many patients, topical treatments remain the first line of defense against atopic dermatitis. While corticosteroids have been the mainstay of treatment for decades, newer, non-steroidal options are becoming available. Crisaborole (Eucrisa) is a topical PDE4 inhibitor that reduces inflammation and can be used on sensitive areas of the skin. Another option, ruxolitinib (Opzelura), a topical JAK inhibitor, has recently gained approval for the treatment of mild to moderate AD.
4. Light Therapy
   Phototherapy, or light therapy, remains a valuable option for treating more severe or widespread cases of atopic dermatitis. Narrowband UVB therapy helps to reduce inflammation and itching by slowing down the skin's immune response. While this treatment requires regular visits to the dermatologist, many patients find it to be an effective, steroid-free option for long-term management.

The Role of Skin Care in Managing Atopic Dermatitis
In addition to advanced treatments, managing atopic dermatitis often involves daily skincare routines to maintain skin hydration and prevent flare-ups. Moisturizers that are fragrance-free and designed for sensitive skin can help restore the skin barrier and keep irritants out. Avoiding triggers, such as harsh soaps or extreme temperatures, can also reduce the frequency of flares.

At MDCS Dermatology, we work closely with our patients to create personalized treatment plans that incorporate both advanced therapies and lifestyle adjustments. Our goal is to not only treat the symptoms but also improve the overall well-being of those suffering from this chronic condition.

Conclusion
With the recent advances in treatment options for atopic dermatitis, there is new hope for those who have long struggled with this condition. Whether it’s biologic therapies, JAK inhibitors, or innovative topical treatments, we now have more tools than ever to help manage and even dramatically improve symptoms. If you or a loved one are living with atopic dermatitis, consider visiting MDCS Dermatology for a comprehensive evaluation and a personalized treatment plan.

Dr. Lauren Penzi is a board-certified dermatologist at MDCS Dermatology. She specializes in medical dermatology, including the treatment of eczema, psoriasis, and skin cancer. Dr. Penzi is committed to helping her patients achieve healthy, clear skin through a combination of advanced treatments and personalized care.

If you're struggling with this condition, book an appointment with Dr. Lauren Penzi and the team at MDCS Dermatology for a comprehensive treatment plan. Book here now!

Know more about Atopic Dermatitis in the section.

For more information, visit our website at www.mdcsderm.com or contact MDCS Dermatology directly. Your journey to healthier skin starts here!